GlobalNextGenerationSequencingNGSMarket.jpg

Next Generation Sequencing (NGS) Market document provides a comprehensive synopsis on the study for market and how it is impacting the Healthcare industry. By applying best-practice models and research methodologies, complete market analysis is performed in this market report to make sure that the report provides accurate market segmentation and insights for the success of client’s business.

Next Generation Sequencing (NGS) Market business report provides accurate market research that aids identify business areas that are performing well, those that need more attention, and also those that business should perhaps give up. If business has got their pulse on what customer is thinking, they can create products that solve their issues, reach out to them when they are most ready to listen, and help them become loyal ambassadors. The universal Next Generation Sequencing (NGS) Market report makes it possible, to follow what customers are talking about, listening to them, and then delivering on their needs with its timely customer-cantered market research.

The global next generation sequencing (NGS) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 17.1% in the forecast period of 2022 to 2029 and is expected to reach USD 29,307.13 million by 2029. Wide portfolio offered by major players and use of NGS in drug development is expected to act as driver for the next generation sequencing (NGS) market growth.

Get PDF Sample of Global Next Generation Sequencing (NGS) Market report: – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Next Generation Sequencing (NGS) Market Scope and Market Size

The next generation sequencing (NGS) market is segmented on basis of product, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the global next generation sequencing (NGS) market is segmented into instrument, consumables, and services. In 2022, the instrument segment is expected to dominate the global next generation sequencing (NGS) market as the instruments are the major component in next generation sequencing procedures.
  • On the basis of application, the global next generation sequencing (NGS) market is segmented into diagnostic, drug discovery, biomarker discovery, precision medicine, agriculture and animal research. In 2022, the diagnostic segment is expected to dominate the global next generation sequencing (NGS) market due to the fact that clinical laboratories have increasingly adopted the NGS for routine diagnosis because it has the potential to deliver precise test result and provide excellent treatment regime.
  • On the basis of end user, the global next generation sequencing (NGS) market is segmented into hospitals & clinics, research centres and academic & government institutes, pharmaceutical & biotechnology companies. In 2022, research center and academic & government institutes is expected to dominate the global next generation sequencing (NGS) market as research related to next generation sequencing for chronic disease and personalized medicine is being conducted mainly by these institutes which is driving the segment growth.

Gain More Insights into the Global Next Generation Sequencing (NGS) Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Global Next Generation Sequencing (NGS) Market Regional Analysis/Insights

The next generation sequencing (NGS) market is analysed and market size information is provided by the product, application and end user as referenced above.

The countries covered in the next generation sequencing (NGS) market report are the U.S., Canada and Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Ireland, and Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

Key Market Competitors Covered in the Report

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • QIAGEN
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Roche Sequencing (A subsidiary of F. Hoffman La Roche)
  • BGI (A subsidiary of BGI Group)
  • Oxford Nanopore Technologies plc
  • MACROGEN CO., LTD.
  • DNASTAR
  • Geneious
  • Partek Incorporated
  • PerkinElmer Inc.
  • Takara Bio Inc.
  • bioMérieux SA
  • Pacific Biosciences of California, Inc.
  • GENEWIZ
  • 10x Genomics
  • New England Biolabs
  • Hamilton Company

Top Trending Reports: –

About us: –

Data bridge market research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and ha bridge market research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact us: –

Data bridge market research

Us: +1 888 387 2818

Email: – corporatesales@databridgemarketresearch.com

admin
Latest posts by admin (see all)

URL